Voyager Technologies (VOYG)
Defence-services + Starlab-JV stake — clean LEO-station optionality but RSI 73.8 makes the entry mathematically wrong.
Investment Research · Photoncap-style deep dive · v1 of "Voyager Technologies" · 2026-05-22
What Voyager physically does
Voyager Technologies is a three-segment business: (1) Defence and National Security — engineering services, payload integration, secure-comms for DoD, intelligence community, and NASA; (2) Space Solutions — the Bishop airlock on ISS (only commercial airlock currently operational), Astroport astronaut-training mock-up, Lemur-2 commercial CubeSat constellation (~100 satellites for AIS-ship-tracking and weather data); and (3) the Starlab JV — Voyager's 35-40% stake in the consortium (Airbus, Mitsubishi, Hilton) developing a commercial successor to the ISS for the post-2030 commercial-LEO-economy. Starlab is a single-launch 8m-diameter modular station with 450 cubic metres pressurised volume, target-capacity 4 crew.
The bet is that NASA's Commercial LEO Destinations (CLD) program migrates the LEO-station market from government-owned (ISS retire ~2030) to commercial-services-procurement, and Voyager-via-Starlab captures one of two NASA-contracted services slots.
Product roadmap
Bishop airlock: operational on ISS since 2020, ~6-8 commercial deployments per year. Astroport: ground-based commercial mock-up facility. Lemur-2 constellation: 100+ satellites, operational, $40-60m annual revenue, 5-10% operating margin. JANUS pressurised module: planned ISS attachment 2026-2027. Starlab: launch target 2028-2030, first commercial revenue 2030-2032. Defence-segment products are heterogeneous engineering services — no single hardware product line. The competitive perimeter VOYG does not contend in: launch, large-scale satellite operations, direct-to-handset comms.
The financial print
FY2024 revenue approximately $145m (S-1 / Q4 2024 reporting). IPO mid-2025 at $30. FY2025 revenue approximately $190m. Bernstein "buy" with FY2026 at $230-280m; Morgan Stanley "neutral" at $200-250m. Cash post-IPO ~$300m against $20m quarterly burn; 12-quarter runway. Stock at $42.97 is +43% from IPO and +34.8% vs 50MA. Q1 2026 earnings drop May 28, 2026 — the binary for Defence/NS growth rate and Starlab capex trajectory.
Customer mix today
In FY2024: ~60% US government direct (DoD, NASA, IC), ~15% NASA-specific (Bishop + CLD development funding), ~15% commercial (Axiom, SpaceX engineering services, Lemur-2 customers), ~10% allied government / international. By Q1 2026 the shift is toward Space-Force space-domain-awareness contracting (+25% YoY in classified-segment revenue) and modest international expansion via Airbus and Mitsubishi partnerships. Government concentration remains the dominant feature.
What's actually happening at NASA CLD
CLD Phase-1 funded preliminary designs from Voyager (Starlab), Blue Origin (Orbital Reef), Axiom Space, and Northrop (Cygnus-Heritage). Phase-2 down-select to two stations is expected late 2026 / early 2027. Conditional contract value to the winners is $1.5-3bn over 8 years post-ISS-retire. Handicap: Axiom is most likely first selection (on-ISS commercial-module record, Saudi PIF backing). The second slot is approximately 50/50 between Voyager-Starlab and Blue Origin-Orbital Reef — Voyager has international-consortium strength and the Hilton commercial-tourism angle; Blue Origin has deeper pockets but reported consortium friction with Sierra Space and Boeing through 2024-2025. Morgan Stanley February 2026 note pegs conditional-NPV at $20+ per share if VOYG wins.
The competitive threat / Axiom
Axiom Space has commercial modules already attached to ISS, has flown four privately-funded astronaut missions, and has Saudi PIF strategic investment ($350m, 2024). Axiom is the presumed-favourite for Phase-2 selection. Blue Origin's Orbital Reef is the secondary competitor with deep balance sheet but consortium-friction risk. The wildcard is SpaceX Starship-as-station — preliminary NASA discussions per industry chatter but no formal CLD bid. China's Tiangong is excluded from Western markets and constrains rather than competes.
The terminal risk
CLD Phase-2 elimination collapses the optionality. Starlab JV cap-table dilution is the second risk — Airbus pro-rata raises plus rumoured Saudi PIF / Mubadala / KARI partner additions could shrink Voyager's effective stake from 35-40% to 20-25% by launch. ISS retirement slipping past 2030 delays the entire revenue ramp. Trump-administration NASA-priority pivot (Mars over LEO) could descope CLD entirely.
Bull / Gap / Optionality
Bull
1. CLD Phase-2 selection. If Starlab wins, conditional-NPV is $20+ per share (Morgan Stanley February 2026). ~50% probability.
2. Defence/NS segment compounding 25%+. FY2026 NDAA allocated ~$1.5bn incremental space-domain-awareness funding; Voyager is one of ~15 prime contractors competing for shares. Segment alone could be $300m+ by FY27 at 8-12% OpMargin.
3. Voyager-Redwire M&A speculation. Per Bloomberg June 2025, a combination would create a $1bn-revenue space-services prime. Recurring rumour through 2026.
4. International consortium structure. Mitsubishi-JAXA pipeline plus Airbus-ESA pipeline plus Hilton-commercial-tourism creates customer diversification that Axiom and Blue Origin cannot match.
Gap
1. RSI 73.8 — most-extended pure-play after RDW. +34.8% vs 50MA into a Q4 binary catalyst is asking the chart to do all the lifting. Asymmetric downside if CLD Phase-2 eliminates.
2. CLD outcome is 50/50. A literal coin-flip on $20+ per share of conditional NPV. Position sizing this requires accepting that half the time the equity halves.
3. Starlab JV dilution. Saudi PIF / Mubadala / KARI interest in joining the consortium is dilutive; future capital rounds at the JV level reduce Voyager's economic stake.
4. Operating-margin trajectory uncertainty. Morgan Stanley flagged defence-segment margin as "structurally constrained by competitive pressure." Breakeven date not in 2026 visibility.
Optionality
| Event | Date / window | Direction |
|---|---|---|
| Q1 2026 earnings | May 28 2026 | Binary on defence growth + Starlab capex |
| Defence FY27 budget | Q3 2026 | Bull if SDA funded |
| CLD Phase-2 down-select | Q4 2026 / Q1 2027 | Binary on Starlab thesis |
| Starlab JV funding round | H1 2027 | Bear if dilutive |
| Voyager-Redwire M&A | Open | Bull if announced |
The trade
SKIP at $42.97. Entry zone $40.82-$45.12 is current ±5%, but RSI 73.8 EXTENDED into a literal 50/50 binary catalyst is the wrong asymmetric bet. The expected value is positive only if you can size small enough to tolerate the 40-50% drawdown on CLD elimination — but at RSI 73.8 you cannot trust the stop to hold above $32. I would re-engage at $30-33 (pullback to the 50MA / IPO-baseline support) or wait for CLD Phase-2 confirmation and buy the post-event gap-fill on the way up. The cleaner expression for "commercial-LEO-station" theme is to wait — there is no public Axiom equivalent (private), so the only LEO-station tradeable is VOYG, and it has to be bought at the right price not at any price. Conviction: 3 / 10.
ticker: SATL name: Satellogic theme: Space Aerospace bucket: C conviction: 2 entryzonelo: 9.82 entryzonehi: 10.86 currentprice: 10.34 pricedate: 2026-05-22 positionsizepct: 0.0 stoploss: 7.63 thesisoneline: Sub-scale EO operator structurally weaker than PL/BKSY; RSI 70.3 melt-up does not change the cap-structure problem — skip outright. catalystnext: Mark VII first launch catalystdate: 2026-11-15 rsi: 70.3 vs50ma: 35.5 forwardpe: 0.0 themecycleposition: late customermixsummary: Latin American government ~40%, commercial mining/energy ~25%, US/EU defence ~20%, APAC ~15%. terminalriskoneline: Mark VII slippage or capital raise at distressed valuation forces dilutive raise with no equity-holder negotiating power. bulldriverscount: 4 gapriskscount: 4 optionalitycount: 5 lastearningsdate: 2025-09-30 nextearnings_date: 2026-09-30